Searched for
BIOTECH PUBLIC MARKETS
Team Europe to visit Assam on June 8-9 to launch India's first Blue Valley clusterGuwahati, Assam, is preparing to welcome a distinguished European Union delegation on June 8-9, as part of a mission to strengthen ties bet...- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Q-Line Biotec shares to list today. Check GMP ahead of debutQ-Line Biotech is poised for a strong stock market debut on Friday. Investor demand appears robust, with grey market trends showing a signi...
- IPO calendar: 3 companies set to launch public offers this week; check detailsThis comes as markets continue to witness sharp downswings and muted recoveries, with oil prices remaining elevated amid the seesaw politic...
- Why SpaceX's mega IPO may not signal a broader rebound in listingsSpaceX's huge IPO is set to capture global attention. However, experts believe this event may not reflect the true health of the broader IP...
- Global Market: Hong Kong IPO boom draws rising interest from overseas companiesHong Kong's stock market is seeing more foreign companies file for listings. Firms from countries like Indonesia and South Korea are explor...
- Flipkart puts IPO on ice; Rapido's $240 million raiseFlipkart has hit pause on its IPO in a jittery market. This and more in today's ETtech Top 5.
- US market today: Biotech firm Odyssey hits nearly $900 million valuation as shares rise in Nasdaq debutOdyssey Therapeutics debuted on Nasdaq with an 11.1% surge, reaching a $899.9 million valuation. The autoimmune disease specialist successf...
- US stocks today: Space analytics firm HawkEye 360 valued at $3.15 billion after NYSE debutHawkEye 360's stock surged 30% on its Thursday debut, reaching a $3.15 billion valuation after raising $416 million in its U.S. IPO. The de...
- Deeptech bets heat up; Paytm, PB Fintech, Meesho earningsHappy Thursday! VCs are doubling down on India’s deeptech, with early-stage bets leading the charge. This and more in today’s ETtech Mornin...
- Claire Mazumdar: A silent force behind a $1.6 billion firm may write Biocon's future scriptsBiocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...
- Most US companies seen sticking with quarterly reportingU.S. firms may soon have the option to report earnings semi-annually instead of quarterly, a proposal revived by President Trump. While pro...
- Inside China’s ‘Magic’ factories: The tech playbook India can’t ignoreChina's state-of-the-art factories reflect its commitment to innovation, backed by robust research and development initiatives. This enviro...
- US Stocks | Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats upKailera Therapeutics shares surged 62.5% in their Nasdaq debut after raising $625 million in a U.S. IPO priced at the top end of its range....
- Windlas Biotech announces Rs 47 crore buyback at Rs 1,000/share; sets April 24 as record dateWindlas Biotech approved a Rs 47 crore share buyback at Rs 1,000 per share via the tender route, with April 24 set as the record date. The ...
- Capital with purpose: How capital markets are shaping the future of medicine with Dheeraj ChinthalapellyDheeraj Chinthalapelly, with a decade and a half of experience in global capital markets, shares his journey navigating the biotech investm...
- US IPO hopefuls forge ahead with listing plans amid market swingsCompanies across sectors have resumed IPO roadshows despite Middle East tensions, signalling pent-up demand in the pipeline. Analysts expec...
- BIRAC fuels innovation with Rs 4,200 crore funding across 15 lakh startups and entrepreneursIndia's Biotechnology Industry Research Assistance Council, BIRAC, marked its 14th Foundation Day. It has significantly boosted India's bio...
- Biotech it to the market: India’s Bioeconomy can reach $1.2 trillion by 2047 but only with bold capital-market reformsIndia must create a special listing framework for research-stage companies on its stock exchanges. This will unlock capital for biotech and...
- What’s on the table? Rossari listing performance to decide IPO mart fateOut of the 10 issues, four have seen their share prices more than double from issue prices.
Load More
